Arterial and venous thrombosis


Data from a case-control study published in New England Journal of Medicine in 2003 suggested that atherosclerosis was associated with VTE risk and launched the hypothesis of a link between arterial and venous thrombosis. In this project, we investigate the bidirectional relationship between arterial and venous thrombosis in large population-based cohorts, and explore the impact of atherosclerosis and atherosclerotic risk factors as potential common risk factors.

There is a link between arterial and venous thrombosis (Illustration: MostPhotos.com) 
In this project, we explore whether major arterial cardiovascular diseases (CVD), i.e., myocardial infarction (MI), ischemic stroke and atrial fibrillation (AF) are associated with VTE in prospective cohorts. We further explore whether putative associations are explained by traditional cardiovascular risk factors (age, smoking, obesity, dyslipidemia, diabetes, family history of MI, metabolic syndrome, atherosclerosis). We also investigate the role of common prothrombotic genotypes for the relationship between arterial and venous thrombosis. We investigate the potential of arterial events as triggering factors for VTE, and whether complications after arterial events can mediate the risk of VTE.  

 

Principal investigator: John-Bjarne Hansen

External collaborators: Ellisiv MathiesenMaja-Lisa Løchen (Department of Clinical Medicine, UiT The Arctic University of Norway), Inger Njølstad, Tom Wilsgaard (Department of Community Medicine, UiT The Arctic University of Norway), Frits Rosendaal (Leiden University Medical Center), Kristian Hveem (HUNT Center for Clinical and Molecular Epidemiology)

Publications:

Tondel et al. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review. J Thromb Haemost. 2022; 20: 2173-86.

Sejrup et al. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromso Study. J Thromb Haemost. 2022; 20: 2342-9.

Sejrup  et al. Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromso Study. Res Pract Thromb Haemost. 2020; 4: 247-54.

Hald et al. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromso study. Res Pract Thromb Haemost. 2020; 4: 1004-12.

Hald et al. Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromso Study. TH Open. 2020; 4: e280-e7. 10.1055/s-0040-1716417.

Smabrekke et al. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism. J Thromb Haemost. 2019; 17: 1363-71.

Sejrup et al. Myocardial Infarction as a Transient Risk Factor for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study. Thromb Haemost. 2019; 119: 1358-64.

Rinde et al. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromso Study. J Thromb Haemost. 2019; 17: 749-58.

Hald et al. Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke. J Am Heart Assoc. 2018; 7.

Morelli et al. The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study. TH Open. 2019; 3: e50-e7.

Lind et al. Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromso Study. TH Open. 2017; 1: e66-e72.

Smabrekke et al. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromso Study. J Thromb Haemost. 2017; 15: 2344-51.

Rinde et al. Myocardial infarction and future risk of cancer in the general population-the Tromso Study. Eur J Epidemiol. 2017; 32: 193-201.

Smabrekke et al. Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromso Study. PloS one. 2016; 11: e0163242.

Rinde et al. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromso Study. J Thromb Haemost. 2016; 14: 1183-91.

Rinde et al. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromso Study. J Am Heart Assoc. 2016; 5.

Lind et al. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromso Study. Circ Cardiovasc Genet. 2014; 7: 684-91.

Lind et al. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation. 2014; 129: 855-63.

Hald et al. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study. J Am Heart Assoc. 2014; 3: e000483.

Hald et al. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol. 2014; 34: 226-30.

Braekkan et al. Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. Arterioscler Thromb Vasc Biol. 2012; 32: 487-91.

Hald et al. High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study. Haematologica. 2011; 96: 1189-94.

Hald et al. Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism. Journal of clinical lipidology. 2013; 7: 48-55.

Braekkan et al. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromso study. J Thromb Haemost. 2008; 6: 1851-7.



Members:

Sigrid Kufaas Brækkan
Birgitte Gladsø Tøndel
Vania Maris Morelli
John Bjarne Hansen